Cargando…
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046252/ https://www.ncbi.nlm.nih.gov/pubmed/33852647 http://dx.doi.org/10.1371/journal.pone.0250475 |
| _version_ | 1783678813824090112 |
|---|---|
| author | Patel, Atul T. Lew, Mark F. Dashtipour, Khashayar Isaacson, Stuart Hauser, Robert A. Ondo, William Maisonobe, Pascal Wietek, Stefan Rubin, Bruce Brashear, Allison |
| author_facet | Patel, Atul T. Lew, Mark F. Dashtipour, Khashayar Isaacson, Stuart Hauser, Robert A. Ondo, William Maisonobe, Pascal Wietek, Stefan Rubin, Bruce Brashear, Allison |
| author_sort | Patel, Atul T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8046252 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80462522021-04-21 Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study Patel, Atul T. Lew, Mark F. Dashtipour, Khashayar Isaacson, Stuart Hauser, Robert A. Ondo, William Maisonobe, Pascal Wietek, Stefan Rubin, Bruce Brashear, Allison PLoS One Correction Public Library of Science 2021-04-14 /pmc/articles/PMC8046252/ /pubmed/33852647 http://dx.doi.org/10.1371/journal.pone.0250475 Text en © 2021 Patel et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Patel, Atul T. Lew, Mark F. Dashtipour, Khashayar Isaacson, Stuart Hauser, Robert A. Ondo, William Maisonobe, Pascal Wietek, Stefan Rubin, Bruce Brashear, Allison Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study |
| title | Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study |
| title_full | Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study |
| title_fullStr | Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study |
| title_full_unstemmed | Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study |
| title_short | Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study |
| title_sort | correction: sustained functional benefits after a single set of injections with abobotulinumtoxina using a 2-ml injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046252/ https://www.ncbi.nlm.nih.gov/pubmed/33852647 http://dx.doi.org/10.1371/journal.pone.0250475 |
| work_keys_str_mv | AT patelatult correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT lewmarkf correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT dashtipourkhashayar correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT isaacsonstuart correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT hauserroberta correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT ondowilliam correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT maisonobepascal correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT wietekstefan correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT rubinbruce correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy AT brashearallison correctionsustainedfunctionalbenefitsafterasinglesetofinjectionswithabobotulinumtoxinausinga2mlinjectionvolumeinadultswithcervicaldystonia12weekresultsfromarandomizeddoubleblindplacebocontrolledphase3bstudy |